Results 131 to 140 of about 48,854 (243)

PBPK modeling of the antidepressant doxepin incorporating CYP2D6 genotype for precision pharmacotherapy. [PDF]

Arch Pharm Res
Seok J, Kang N, Lee JJ, Cho CK, Lee YJ.
europepmc   +1 more source

Response: Re: Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis [PDF]

, 2008
Rinaa S. Punglia, Harold J. Burstein, Eric P. Winer, Jane C. Weeks   +3 more
openalex   +1 more source

A functional ancestry-linked regulatory haplotype influences CYP2D6 expression. [PDF]

Pharmacogenomics J
McCoy M.
europepmc   +1 more source

CYP2D6*7 Allele [PDF]

, 2020
openaire   +1 more source

CYP2D6 Poor Metabolizer Status Can Be Ruled Out by a Single Genotyping Assay for the −1584G Promoter Polymorphism [PDF]

, 2003
Andrea Gaedigk, Darren L Ryder, L. DiAnne Bradford, J. Steven Leeder   +3 more
openalex   +1 more source

IDENTIFICATION OF GENES ASSOCIATED WITH QT INTERVAL USING THE 50K CARDIO-METABOLIC SNP CHIP: RESULTS FROM THE WHITEHALL II STUDY

, 2009
Drenos, F, Hingorani, AD, Humphries, SE, Kivamaki, M, Kumari, M, MacFarlane, P, Pallas, J, Palmen, J, Shah, S, Shah, T, Sofat, R, Talmud, PJ, Verzilli, C, Whittaker, J   +13 more
core   +1 more source

CYP2D6*6 Allele [PDF]

, 2020
openaire   +1 more source

CYP2D6*11 Allele [PDF]

, 2020
openaire   +1 more source

Rolapitant Is a Reversible Inhibitor of CYP2D6 [PDF]

, 2019
Sarah M. Glass, Sabrina M. Leddy, Michael Orwin, Garret P. Miller, Kyle A. Furge, Laura Lowe Furge   +5 more
openalex   +1 more source

Clinical Evaluation of Drug-Drug Interactions With Aficamten. [PDF]

Clin Transl Sci
Maharao N, Xu D, Divanji P, Simkins TJ, Li J, Dumitrescu C, Solanki P, Griffith A, Heitner SB, Kupfer S, German P, Lutz JD.   +11 more
europepmc   +1 more source